StockWatch
·
Pharmaceuticals
Board Meeting28 Oct 2026, 05:11 pm

Sudeep Pharma Ltd Board Approves Unaudited Financial Results

AI Summary

Sudeep Pharma Limited announced that its Board of Directors, in a meeting held on October 28, 2026, has approved the Unaudited Standalone & Consolidated Financial Results for the quarter and half-year ended September 30, 2026. The board meeting commenced at 03:10 p.m. and concluded at 04:25 p.m. The limited review report from B S R and Co Chartered Accountants was also submitted, confirming no material misstatements were found, although one subsidiary's financial results were not reviewed.

Key Highlights

  • Board approved unaudited standalone and consolidated financial results.
  • Results are for the quarter and half-year ended September 30, 2026.
  • Board meeting held on October 28, 2026.
  • Limited review report submitted by auditors.
  • One subsidiary's results were not reviewed.